Daewoong Biologics Indonesia

Daewoong Biologics Indonesia is a specialized biotechnology subsidiary of the South Korean pharmaceutical giant Daewoong Pharmaceutical, established to advance regenerative medicine in Southeast Asia. Based in Cikarang, Indonesia, the company operates a state-of-the-art facility that was the first in the country to receive a Class A Stem Cell Laboratory license from the Indonesian Ministry of Health. Its primary business focuses on the processing and supply of umbilical cord-derived mesenchymal stem cells (UC-MSCs) and secretomes for the treatment of degenerative diseases and aesthetic applications. By integrating Daewoong's global R&D expertise with local manufacturing, the company provides high-quality cell therapy products and research services. Daewoong Biologics Indonesia plays a pivotal role in the parent company's strategy to build a comprehensive healthcare hub in Indonesia, encompassing R&D, production, and commercialization.